Hap Trading, LLC Vascular Biogenics Ltd. Call Options Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	SELL	$0.15 - $2.1 $2,070 - $28,980	-13,800 Reduced 57.02%	10,400 $0
Q2 2022 Aug 12, 2022	BUY	$1.22 - $1.95 $3,294 - $5,265	2,700 Added 12.56%	24,200 $10,000
Q1 2022 May 12, 2022	BUY	$1.15 - $1.97 $2,300 - $3,940	2,000 Added 10.26%	21,500 $6,000
Q4 2021 Feb 14, 2022	BUY	$1.92 - $2.53 $17,856 - $23,529	9,300 Added 91.18%	19,500 $2,000
Q3 2021 Nov 10, 2021	SELL	$1.94 - $2.55 $18,818 - $24,735	-9,700 Reduced 48.74%	10,200 $2,000
Q2 2021 Aug 11, 2021	BUY	$1.69 - $2.67 $33,631 - $53,133	19,900 New	19,900 $9,000

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.